Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dextran 70 infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextran 70 |
Inferred relationship |
Some |
|
Dextran 70/dextrose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextran 70 |
Inferred relationship |
Some |
|
Dextran 70/sodium chloride 0.9% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextran 70 |
Inferred relationship |
Some |
|
Dextran 70 in sodium chloride 7.5% infusion solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextran 70 |
Inferred relationship |
Some |
|
Product containing dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextran 70 |
Inferred relationship |
Some |
|
Product containing dextran 70 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70- and hypromellose-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70 only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing only dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70 only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing only dextran 70 and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70 and sodium chloride only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing dextran 70 and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing dextran 70 and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70 60 mg/mL and sodium chloride 75 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Dextran 70 60 mg/mL and sodium chloride 75 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |
Product containing only dextran 70 and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextran 70 |
Inferred relationship |
Some |
1 |